Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Can recovery from depression be achieved?

R C Shelton¹, A J Tomarken

¹Vanderbilt University Medical Center in Nashville, Tennesse, USA. richard.shelton@mcmail.vanderbilt.edu

Psychiatric Services (Washington, D.C.)

|October 31, 2001

Summary

Many depression treatments fail, leading to chronic impairment. This study proposes a new therapeutic approach targeting distinct mood disorder symptoms based on neurochemical pathways, aiming for better treatment outcomes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Molecular analyses of circadian gene variants reveal sex-dependent links between depression and clocks.

Translational psychiatry·2016

Same author

Obesity, but not metabolic syndrome, negatively affects outcome in bipolar disorder.

Acta psychiatrica Scandinavica·2015

Same author

Fibroblasts from patients with major depressive disorder show distinct transcriptional response to metabolic stressors.

Translational psychiatry·2015

Same author

Assessment of a multi-assay, serum-based biological diagnostic test for major depressive disorder: a pilot and replication study.

Molecular psychiatry·2011

Same author

Altered expression of genes involved in inflammation and apoptosis in frontal cortex in major depression.

Molecular psychiatry·2010

Same author

Can pharmacotherapists be too supportive? A process study of active medication and placebo in the treatment of depression.

Psychological medicine·2009

Area of Science:

Neuroscience
Psychiatry
Pharmacology

Background:

Depression treatment often results in incomplete patient response and persistent functional impairment.
Mood disorders exhibit distinct symptom clusters: somatic anxiety, anhedonia (low positive affect), and general distress.
Current treatments may not effectively address all symptom dimensions.

Purpose of the Study:

To present a therapeutic heuristic for depression based on symptom-specific neurochemical pathways.
To guide treatment selection by matching residual symptoms to neurotransmitter systems.
To improve therapeutic outcomes for patients with treatment-resistant depression.

Main Methods:

Review of research on mood disorder symptom components and their neurochemical underpinnings.
Categorization of symptoms based on their association with serotonin, dopamine, and norepinephrine.
Development of a heuristic for selecting serotonergic or catecholaminergic agents.

Main Results:

Somatic anxiety and general distress are significantly modulated by serotonin.
Anhedonia and low motivation are primarily linked to dopamine and norepinephrine systems.
The heuristic suggests serotonergic agents for distress and catecholaminergic agents for anhedonia.

Conclusions:

A symptom-based therapeutic heuristic can optimize depression treatment selection.
Targeting specific neurochemical pathways (serotonergic vs. catecholaminergic) may enhance treatment efficacy.
This approach offers a framework for personalized medicine in mood disorder management.

Related Experiment Videos